September 1, 2009
By:Martha K. Raymond, RN, BSN, BS
An Archives of Internal Medicine study reported that older diabetes patients who started antipsychotic drug therapy had higher overall likelihoods of hyperglycemia.
 |
September 1, 2009
By:Martha K. Raymond, RN, BSN, BS
Tumor necrosis factor blockers can increase risk of lymphoma and other malignancies in pediatric patients, leading the FDA to issue a Boxed Warning mandate for these agents.
|
August 1, 2009
By:Steve Mullett
The FDA has requested that manufacturers of asthma and rhinitis drugs with leukotriene inhibitors as the active ingredient include a psychiatric warning of mood and behavior changes among some users.
|
August 1, 2009
By:Steve Mullett
The contents of Lovaza omega-3 capsules can pit or dissolve Styrofoam cups; they are now listed on the ISMP's "do not crush" list.
|
August 1, 2009
By:Steve Mullett
The American Journal of Psychiatry has published a study documenting an association between use of stimulants for ADHD and sudden childhood deaths.
|
July 1, 2009
By:Steve Mullett
Proton-pump inhibitors used for acid reflux have been associated with a 30% increase in risk of contracting pneumonia, according to a recent study.
|
July 1, 2009
By:Steve Mullett
The use of thiazolidinediones Actos or Avandia for treating type 2 diabetes raises the risk of bone fractures, based on the results of a large-scale, 2-year study.
|
June 1, 2009
By:Steve Mullett
FDA now permits Tamiflu and Relenza use in younger children, and at different dosages in older children, in response to H1N1 flu outbreak.
|
June 1, 2009
By:Steve Mullett
Two medical societies have issued joint guidelines warning pregnant mothers to avoid valproate (Depakote) and two other antiseizure drugs because of links to spina bifida, cleft palate, and lower child IQs.
|
| 
Practice Tools
